The global neurorehabilitation market share is expected to witness significant growth in the coming years. Neurorehabilitation refers to a specialized branch of healthcare that focuses on the recovery and rehabilitation of individuals with neurological disorders or injuries. These conditions can range from stroke, traumatic brain injury, spinal cord injury, multiple sclerosis, Parkinson's disease, and many others.

One of the key factors driving the growth of the neurorehabilitation market is the increasing prevalence of neurological disorders worldwide. According to the World Health Organization (WHO), neurological disorders affect millions of people globally, with an estimated 6.8 million deaths occurring each year due to these conditions. This rising burden has created a strong demand for effective neurorehabilitation therapies and treatments.

Advancements in technology have also played a crucial role in shaping the neurorehabilitation market landscape. Innovations such as robotics, virtual reality (VR), augmented reality (AR), brain-computer interfaces (BCIs), and wearable devices have revolutionized the field by These advancements have allowed for more personalized and immersive rehabilitation experiences, leading to improved outcomes for patients.

The Neurorehabilitation Market Size was assessed at USD 1.29 billion in 2022, and is predicted to increase at a CAGR of 9% from 2023 to 2030, to reach USD 2.58 billion.

Get Free Sample Report @ https://www.snsinsider.com/sample-request/1261

KEY MARKET SEGMENTATION:

By Type

  • Wearable Devices
  • Neuro-Robotic Devices
  • Brain-Computer Interface (BCIs)
  • Non-Invasive Stimulators

By Application type

  • Parkinson's Disease
  • Spinal cord injury
  • Brain stroke
  • Cerebral palsy
  • Multiple sclerosis
  • Schizophrenia etc.

By End-User type

  • Hospitals
  • Cognitive Care Centers
  • Clinics

Some of the major key players are as follows: Abbott Laboratories, BioScience Managers Ltd, Helius Medical Technologies, Medtronic Inc, Hocoma AG, Ekso Bionics Holdings Inc, Bionik Laboratories Corp, and other players.

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND),

Website: https://www.snsinsider.com